Metabolic effects of short-chain ceramide and glucosylceramide on sphingolipids and protein kinase C.
Recent studies have identified a potential role for glucosylceramide (GlcCer) in growth promotion and hormonal signalling. In an effort to demonstrate a growth-promoting activity of GlcCer, we prepared a GlcCer having a short-chain acid (octanoyl), in the belief that this glycolipid could be absorbed more readily and more uniformly by cultured cells. By using a mixture of two specific lecithins, dioleoylglycerophosphocholine and 1-stearoyl-2-palmitoylglycerophosphocholine, we were able to prepare dispersions containing a high molar proportion of the GlcCer and the related ceramide, octanoyl sphingosine. Unexpectedly, both sphingolipids inhibited protein and DNA synthesis in Madin-Darby canine kidney cells and produced large increases in the levels of the natural lipids, GlcCer, ceramide, free sphingosine, and an amine that may be glucosylsphingosine (GlcSph). Decreases were seen in the level of sphingomyelin and the proportion of protein kinase C in the cell membranes. The level of lactosylceramide was diminished by octanoyl GlcCer but elevated considerably by octanoyl sphingosine. Diacylglycerols were increased by the lecithins in the liposomes, but the exogenous sphingolipids had no effect. Octanoyl sphingosine labeled in the sphingoid base yielded labeled GlcCer and sphingomyelin labeled in both long-chain and very-long-chain fatty acid families, as well as the octanoyl version. The two families of ceramides, however, had relatively little radioactivity. Some of these changes are attributed to rapid hydrolysis of the added lipids with the formation, particularly from the ceramide, of sphingosine and its anabolic metabolite, GlcSph. Several observations support the idea that the octanoyl sphingosine inhibited the phosphocholinetransferase that synthesizes sphingomyelin while the octanoyl GlcCer inhibited GlcCer beta-glucosidase and GlcCer galactosyltransferase. The use of unnatural short-chain lipids in the study of cell growth and other phenomena may result in unexpected changes in related metabolites and the findings from such experiments should therefore be interpreted cautiously.
Abe
A
A
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0676.
Wu
D
D
Shayman
J A
JA
Radin
N S
NS
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002518:Ceramides / Q000378:metabolism / Q000494:pharmacology*; D004075:Diglycerides / Q000378:metabolism; D004285:Dogs; D005963:Glucosylceramides / Q000494:pharmacology*; D007668:Kidney; D007700:Kinetics; D008081:Liposomes; D011493:Protein Kinase C / Q000378:metabolism*; D013107:Sphingolipids / Q000302:isolation & purification / Q000378:metabolism*; D013109:Sphingomyelins / Q000302:isolation & purification / Q000378:metabolism; D013110:Sphingosine / Q000378:metabolism; D013329:Structure-Activity Relationship
D002518:Ceramides; D004075:Diglycerides; D005963:Glucosylceramides; D008081:Liposomes; D013107:Sphingolipids; D013109:Sphingomyelins; D011493:Protein Kinase C; D013110:Sphingosine